Nurix Therapeutics (NRIX) Is Down 7.4% After Wider 2025 Losses And New ESOP Share Shelf - What's Changed [Yahoo! Finance]
Nurix Therapeutics, Inc. (NRIX): A Bull Case Theory [Yahoo! Finance]
Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts [Yahoo! Finance]
Nurix Therapeutics (NASDAQ:NRIX) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $30.00. They now have an "outperform" rating on the stock.
Nurix Therapeutics (NASDAQ:NRIX) was given a new $35.00 price target on by analysts at Stifel Nicolaus.